Take Hope Further: Verzenio HCP Campaign

Women diagnosed with high-risk early breast cancer previously had limited choices beyond endocrine therapy, leaving them to rely on hope that their cancer would not return or spread. Driven by the criticism of “pink washing” in breast cancer advocacy, the campaign presented Verzenio as a groundbreaking solution. As the first new treatment for early breast cancer in more than a decade, Verzenio offered patients more than hope — it delivered improved survival and real progress for patients.